Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Decibel Therapeutics stock

Learn how to easily invest in Decibel Therapeutics stock.

Decibel Therapeutics Inc is a biotechnology business based in the US. Decibel Therapeutics shares (DBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Decibel Therapeutics employs 62 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Decibel Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DBTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Decibel Therapeutics stock price (NASDAQ: DBTX)

Use our graph to track the performance of DBTX stocks over time.

Decibel Therapeutics shares at a glance

Information last updated 2022-06-24.
Latest market close$2.24
52-week range$1.83 - $9.75
50-day moving average $2.27
200-day moving average $4.70
Wall St. target price$16.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.20

Buy Decibel Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
Financial advice powered by relationships, not commissions.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Decibel Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Decibel Therapeutics price performance over time

Historical closes compared with the close of $2.24 from 2022-06-27

1 week (2022-06-21) -3.45%
1 month (2022-05-27) -4.27%
3 months (2022-03-29) -23.81%
6 months (2021-12-29) -52.54%
1 year (2021-06-29) -75.00%
2 years (2020-06-25) N/A
3 years (2019-06-25) N/A
5 years (2017-06-25) N/A

Decibel Therapeutics financials

Gross profit TTM $0
Return on assets TTM -17.51%
Return on equity TTM -35.65%
Profit margin 0%
Book value $5.13
Market capitalisation $62.2 million

TTM: trailing 12 months

Decibel Therapeutics share dividends

We're not expecting Decibel Therapeutics to pay a dividend over the next 12 months.

Decibel Therapeutics overview

Decibel Therapeutics, Inc. , a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO and AAV. 201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV. 103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.

Frequently asked questions

What percentage of Decibel Therapeutics is owned by insiders or institutions?
Currently 20.2% of Decibel Therapeutics shares are held by insiders and 64.535% by institutions.
How many people work for Decibel Therapeutics?
Latest data suggests 62 work at Decibel Therapeutics.
When does the fiscal year end for Decibel Therapeutics?
Decibel Therapeutics's fiscal year ends in December.
Where is Decibel Therapeutics based?
Decibel Therapeutics's address is: 1325 Boylston Street, Boston, MA, United States, 02215
What is Decibel Therapeutics's ISIN number?
Decibel Therapeutics's international securities identification number is: US24343R1068

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site